Applied Molecular Transport Inc.
NASDAQ:AMTI
Applied Molecular Transport Inc.
Net Issuance of Debt
Applied Molecular Transport Inc.
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Applied Molecular Transport Inc.
NASDAQ:AMTI
|
Net Issuance of Debt
-$270k
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Debt
$12.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
181%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Debt
$2.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Debt
-$45.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Applied Molecular Transport Inc.'s Net Issuance of Debt?
Net Issuance of Debt
-270k
USD
Based on the financial report for Dec 31, 2022, Applied Molecular Transport Inc.'s Net Issuance of Debt amounts to -270k USD.
What is Applied Molecular Transport Inc.'s Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
-44%
Over the last year, the Net Issuance of Debt growth was -17%. The average annual Net Issuance of Debt growth rates for Applied Molecular Transport Inc. have been -44% over the past three years .